Dinakion MM Injection 2 mg/0.2 ml contains Phytomenadione, also known as Vitamin K1, in a concentrated, ready-to-use form. This fat-soluble vitamin is essential for normal blood coagulation and plays a critical role in preventing bleeding disorders, especially in neonates and infants. The “MM” (Miniature) formulation delivers a small, precise dose suitable for newborns, infants, and pediatric patients, allowing safe and accurate administration.

Phytomenadione is necessary for the synthesis of clotting factors II (prothrombin), VII, IX, and X in the liver, which are crucial for proper blood clotting. Vitamin K deficiency can lead to Vitamin K Deficiency Bleeding (VKDB) in newborns, which may result in life-threatening hemorrhages if left untreated. Dinakion MM Injection is formulated to provide rapid and effective prophylaxis or treatment of such conditions.

The compact 0.2 ml injection is convenient for neonatal and pediatric use, ensuring precise dosing with minimal risk of overdose. It is typically administered by trained healthcare professionals in hospital or clinical settings.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Dinakion MM Injection 2 mg/0.2 ml is indicated for:

• Prevention of Vitamin K Deficiency Bleeding (VKDB) in newborns, especially preterm or low-birth-weight infants

• Treatment of Vitamin K deficiency due to poor dietary intake, malabsorption, or liver disease

• Correction of hypoprothrombinemia associated with anticoagulant therapy (e.g., warfarin)

• Supportive therapy in infants with cholestasis, biliary obstruction, or other fat-malabsorption disorders

It is a vital intervention to reduce the risk of bleeding complications in neonates and vulnerable pediatric patients.

Dosage and Administration

• Neonates: A single 2 mg (0.2 ml) intramuscular injection at birth is commonly recommended to prevent VKDB.

• Infants and Children: Dose is weight-based and should be prescribed by a pediatrician.

• Adults (if indicated): Dose adjustments are determined by a physician based on clinical need.

Administration Notes:

• Administer via intramuscular injection; avoid intravenous use unless prescribed.

• The injection should be given under aseptic conditions by trained healthcare personnel.

• Shake the vial gently before use to ensure proper dispersion of the solution.

Precautions

• Contraindicated in patients with hypersensitivity to Phytomenadione or any component of the injection.

• Caution in individuals with severe liver or kidney impairment.

• Monitor coagulation parameters when used to correct over-anticoagulation.

• Avoid repeated dosing without medical guidance, especially in neonates.

• Use only the recommended dose for infants to prevent adverse reactions.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Dinakion MM Injection is generally safe and well tolerated. Rare side effects may include:

• Mild pain, redness, or swelling at the injection site

• Allergic reactions such as rash or itching

• Flushing or warmth during administration

• Very rare hypersensitivity or anaphylactic reactions

Serious adverse reactions are extremely uncommon when used in recommended doses.

Storage

Store below 25°C in a cool, dry place, away from light. Keep out of reach of children. Do not use if the solution is discolored or contains particles.

Dinakion MM Injection 2 mg/0.2 ml is an effective and safe form of Vitamin K1 supplementation for neonates, infants, and pediatric patients, preventing deficiency-related bleeding and supporting normal coagulation under professional medical supervision.